Inno-206

Biopsy-proven, Positive Lymph Node(s)

Laura M. Spring, MDPhase 3Active

BB

67/ 100

Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence: 53/ 100
Competitive Position: 95/ 100

Competitive context

15 Active assets in the Biopsy-proven, Positive Lymph Node(s) cohort.

Asset / Sponsor	Phase	Rating
Cyclophosphamide Laura M. Spring, MD	Phase 3	BB
Indocyanine Green Isabelle Henskens	Phase 4	BB
TAMOXIFEN National Cancer Institute (NCI)	Phase 3	BB
Inno-206 National Cancer Institute (NCI)	Phase 3	BB
Cyclophosphamide National Cancer Institute (NCI)	Phase 3	B

View all 24 →

Same molecule, other indications

Inno-206 is also rated in:

adult acute lymphoblastic leukemiaDormant

BBB

Indicative ·

77 / 100

plasma cell myelomaDormant

BBB

Indicative ·

77 / 100

Recurrent Adult Acute Lymphoblastic LeukemiaDormant

BBB

Indicative ·

77 / 100

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.